We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+2.95%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13.7B
AUM Growth
+$950M
(+7.4%)
Cap. Flow
+$723M
Cap. Flow
% of AUM
5.27%
Top 10 Holdings %
Top 10 Hldgs %
11.77%
Holding
2,830
New
300
Increased
700
Reduced
765
Closed
275
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corning
GLW
|
+$45.6M |
| 2 |
Accenture
ACN
|
+$41.1M |
| 3 |
OA
Orbital ATK, Inc.
OA
|
+$33.7M |
| 4 |
Hormel Foods
HRL
|
+$32.9M |
| 5 |
PACCAR
PCAR
|
+$32.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$61.7M |
| 2 |
RFMD
RF MICRO DEVICES INC
RFMD
|
+$23.5M |
| 3 |
ORB
ORBITAL SCIENCES CORP
ORB
|
+$21.2M |
| 4 |
TAL
TAL INTERNATIONAL GROUP, INC.
TAL
|
+$21.1M |
| 5 |
Hope Bancorp
HOPE
|
+$19.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.82% |
| 2 | Healthcare | 14.78% |
| 3 | Industrials | 11.92% |
| 4 | Financials | 9.77% |
| 5 | Consumer Discretionary | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Clorox
CLX
$11.6B
| $8.09M | 0.06% |
73,313
-9
| -0% | -$977 |
|
377
MetLife
MET
$61B
| $8.09M | 0.06% |
179,529
-22,862
| -11% | -$1.03M |
|
|
ISSI
378
DELISTED
INTEGRATED SILICON SOLUTN INC
ISSI
| $7.98M | 0.06% |
446,252
-428,891
| -49% | -$7.2M |
|
|
WES
379
DELISTED
Western Gas Partners Lp
WES
| $7.85M | 0.06% |
119,199
-1,887
| -2% | -$130K |
|
380
Cintas
CTAS
$82.4B
| $7.82M | 0.06% |
383,356
+307,260
| +404% | +$6.23M |
|
381
Affiliated Managers Group
AMG
$9.46B
| $7.65M | 0.06% |
35,618
+34,837
| +4,461% | +$7.35M |
|
382
Omega Healthcare
OHI
$15.4B
| $7.64M | 0.06% |
188,280
-205,161
| -52% | -$8.49M |
|
383
Adobe
ADBE
$89.5B
| $7.44M | 0.05% |
100,624
+11,127
| +12% | +$830K |
|
384
Palo Alto Networks
PANW
$264B
| $7.29M | 0.05% |
299,424
-84
| -0% | -$1.88K |
|
|
SCHW
385
Charles Schwab
SCHW
$177B
| $7.26M | 0.05% |
238,517
-286,777
| -55% | -$8.31M |
|
386
CSX Corp
CSX
$98.6B
| $7.22M | 0.05% |
654,414
+171,693
| +36% | +$1.97M |
|
|
RGP
387
DELISTED
REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS
RGP
| $7.17M | 0.05% |
313,549
+264
| +0.1% | +$6.22K |
|
388
Avient
AVNT
$3.45B
| $6.79M | 0.05% |
181,837
+11,040
| +6% | +$419K |
|
|
SYNT
389
DELISTED
Syntel Inc
SYNT
| $6.71M | 0.05% |
129,716
+447
| +0.3% | +$21.3K |
|
|
SIAL
390
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $6.68M | 0.05% |
48,365
-63,731
| -57% | -$8.79M |
|
391
DuPont de Nemours
DD
$18.6B
| $6.61M | 0.05% |
54,449
-1,703
| -3% | -$202K |
|
|
FLIR
392
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $6.56M | 0.05% |
209,685
+202,905
| +2,993% | +$6.4M |
|
393
Duke Energy
DUK
$102B
| $6.5M | 0.05% |
84,645
-3,455
| -4% | -$280K |
|
394
UnitedHealth
UNH
$382B
| $6.3M | 0.05% |
53,266
-18,332
| -26% | -$2.04M |
|
395
Graco
GGG
$12.9B
| $6.22M | 0.05% |
258,654
-3,990
| -2% | -$99.5K |
|
396
Citigroup
C
$222B
| $6.21M | 0.05% |
120,470
+39,112
| +48% | +$1.99M |
|
397
Kinder Morgan
KMI
$73.1B
| $6.16M | 0.04% |
146,541
-12,447
| -8% | -$515K |
|
398
Bank of America
BAC
$435B
| $6.13M | 0.04% |
398,559
+93,087
| +30% | +$1.5M |
|
|
HDV
399
iShares Core High Dividend ETF
HDV
$14.5B
| $6.08M | 0.04% |
405,490
-67,830
| -14% | -$1.04M |
|
400
Transocean
RIG
$5.92B
| $6.08M | 0.04% |
414,544
+336,103
| +428% | +$5.45M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2015 Portfolio in Review
As of Q1 2015, Glenmede Trust held 2,830 positions worth $13.7B, up 7.4% from $12.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Glenmede Trust deployed $723M of net new capital in Q1 2015, opening 300 new positions and adding to 700 existing holdings. Its largest new stake was Qorvo: 411,283 shares worth $32.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was NOV, an estimated $18.7M trimmed.
- Glenmede Trust's largest Q1 2015 buy was Qorvo: 411,283 shares worth $32.8M.
- Glenmede Trust added most to Corning in Q1 2015, an estimated $45.6M increase.
- Glenmede Trust's biggest Q1 2015 reduction was NOV, cutting an estimated $18.7M.
- Glenmede Trust fully exited Allergan Inc in Q1 2015, selling an estimated $61.7M.
- Glenmede Trust's ten largest holdings make up 12% of its $13.7B portfolio in Q1 2015.
- Glenmede Trust opened 300 new positions and closed 275 in Q1 2015.
- Glenmede Trust's portfolio value rose 7.4% quarter-over-quarter to $13.7B.
Based on Glenmede Trust's 13F filing for Q1 2015, filed 29 Apr 2015.